Independent Director · Context Therapeutics Inc. (CNTX)

Philip Kantoff, MD — Context Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Philip Kantoff, MD at Context Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Philip Kantoff, MD’s full pay file as a PDF — free

More than this page: up to 10 years of Philip’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Philip Kantoff, MD and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Context Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Context Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$43,776$0$67,359$0$111,135
FY2024$43,500—$38,319$0$81,819
FY2023$43,500—$16,333$0$59,833
FY2021$31,617—$56,730$8,750$97,097

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Context Therapeutics Inc. DEF 14A filed April 28, 2026, accession 0001628280-26-027928, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Context Therapeutics Inc. filed document, accession 0001628280-26-027928. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the Context Therapeutics Board Governance Report

$111,135 Philip Kantoff, MD, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Context Therapeutics pays directors a $40,000 cash retainer and $120,000 in Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance

The rest of the Context Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Andy PasternakIndependent Director$159,027
Jennifer Evans Stacey, EsqIndependent Director$122,635
Karen Smith, MDIndependent Director$200,249
Linda WestIndependent Director$127,359
Luke Walker, MDIndependent Director$111,135
Martin LehrDirector—

The full Context Therapeutics compensation record

free company brief

This page is one director within Context Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order CNTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report